

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 7.28137266 |
| 2 | muscle filament sliding (GO:0030049) | 7.28137266 |
| 3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.07601614 |
| 4 | regulation of skeletal muscle contraction (GO:0014819) | 7.07266722 |
| 5 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.48074391 |
| 6 | actin-mediated cell contraction (GO:0070252) | 6.04505624 |
| 7 | skeletal muscle contraction (GO:0003009) | 5.83576034 |
| 8 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.60802498 |
| 9 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.58550403 |
| 10 | plasma membrane repair (GO:0001778) | 5.54454911 |
| 11 | skeletal muscle adaptation (GO:0043501) | 5.24563066 |
| 12 | sarcomere organization (GO:0045214) | 5.18016465 |
| 13 | regulation of cell communication by electrical coupling (GO:0010649) | 5.13515856 |
| 14 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.83974347 |
| 15 | negative regulation of fibrinolysis (GO:0051918) | 4.81027301 |
| 16 | striated muscle contraction (GO:0006941) | 4.75517733 |
| 17 | plasma lipoprotein particle assembly (GO:0034377) | 4.74899526 |
| 18 | myofibril assembly (GO:0030239) | 4.68839912 |
| 19 | actin filament-based movement (GO:0030048) | 4.61801460 |
| 20 | protein-lipid complex assembly (GO:0065005) | 4.57245788 |
| 21 | neuronal action potential propagation (GO:0019227) | 4.50037670 |
| 22 | regulation of fibrinolysis (GO:0051917) | 4.42459659 |
| 23 | skeletal muscle fiber development (GO:0048741) | 4.29232637 |
| 24 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.25570248 |
| 25 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.21718841 |
| 26 | regulation of cholesterol esterification (GO:0010872) | 4.07904532 |
| 27 | regulation of protein activation cascade (GO:2000257) | 4.05625365 |
| 28 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.05428729 |
| 29 | cardiac muscle contraction (GO:0060048) | 4.03026222 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.00469745 |
| 31 | protein carboxylation (GO:0018214) | 4.00469745 |
| 32 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.94619654 |
| 33 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.94619654 |
| 34 | high-density lipoprotein particle remodeling (GO:0034375) | 3.92726547 |
| 35 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.87719332 |
| 36 | glycogen catabolic process (GO:0005980) | 3.86949817 |
| 37 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.86631228 |
| 38 | regulation of complement activation (GO:0030449) | 3.86331391 |
| 39 | muscle contraction (GO:0006936) | 3.83474349 |
| 40 | cardiac myofibril assembly (GO:0055003) | 3.83445245 |
| 41 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.83223703 |
| 42 | myotube cell development (GO:0014904) | 3.82706864 |
| 43 | regulation of relaxation of muscle (GO:1901077) | 3.81858773 |
| 44 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.79505676 |
| 45 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.77144406 |
| 46 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.75389068 |
| 47 | actomyosin structure organization (GO:0031032) | 3.72492073 |
| 48 | response to inactivity (GO:0014854) | 3.71178563 |
| 49 | protein-lipid complex remodeling (GO:0034368) | 3.70015436 |
| 50 | macromolecular complex remodeling (GO:0034367) | 3.70015436 |
| 51 | plasma lipoprotein particle remodeling (GO:0034369) | 3.70015436 |
| 52 | phospholipid efflux (GO:0033700) | 3.67069078 |
| 53 | cholesterol efflux (GO:0033344) | 3.66397465 |
| 54 | reverse cholesterol transport (GO:0043691) | 3.57813607 |
| 55 | blood coagulation, intrinsic pathway (GO:0007597) | 3.57274396 |
| 56 | glucan catabolic process (GO:0009251) | 3.56693685 |
| 57 | regulation of membrane repolarization (GO:0060306) | 3.54473885 |
| 58 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.50674264 |
| 59 | membrane depolarization during action potential (GO:0086010) | 3.50330499 |
| 60 | muscle fiber development (GO:0048747) | 3.48454560 |
| 61 | muscle system process (GO:0003012) | 3.45995082 |
| 62 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.44897614 |
| 63 | neuromuscular synaptic transmission (GO:0007274) | 3.43671201 |
| 64 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.42326092 |
| 65 | negative regulation of cholesterol transport (GO:0032375) | 3.41828452 |
| 66 | negative regulation of sterol transport (GO:0032372) | 3.41828452 |
| 67 | muscle cell cellular homeostasis (GO:0046716) | 3.39698354 |
| 68 | striated muscle adaptation (GO:0014888) | 3.38219058 |
| 69 | striated muscle atrophy (GO:0014891) | 3.36630262 |
| 70 | regulation of actin filament-based movement (GO:1903115) | 3.36365950 |
| 71 | plasma lipoprotein particle organization (GO:0071827) | 3.32971620 |
| 72 | protein-lipid complex subunit organization (GO:0071825) | 3.31943999 |
| 73 | low-density lipoprotein particle remodeling (GO:0034374) | 3.28640828 |
| 74 | cellular polysaccharide catabolic process (GO:0044247) | 3.28330649 |
| 75 | regulation of striated muscle contraction (GO:0006942) | 3.26678137 |
| 76 | negative regulation of lipase activity (GO:0060192) | 3.19801606 |
| 77 | creatine metabolic process (GO:0006600) | 3.19265520 |
| 78 | synaptic vesicle maturation (GO:0016188) | 3.18741862 |
| 79 | regulation of bile acid biosynthetic process (GO:0070857) | 3.18316509 |
| 80 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.18094813 |
| 81 | NADH metabolic process (GO:0006734) | 3.17016069 |
| 82 | complement activation, alternative pathway (GO:0006957) | 3.17009191 |
| 83 | regulation of cofactor metabolic process (GO:0051193) | 3.15991926 |
| 84 | regulation of coenzyme metabolic process (GO:0051196) | 3.15991926 |
| 85 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.15668905 |
| 86 | regulation of cation channel activity (GO:2001257) | 3.15200544 |
| 87 | positive regulation of cation channel activity (GO:2001259) | 3.13557237 |
| 88 | cell communication by electrical coupling (GO:0010644) | 3.12835191 |
| 89 | polysaccharide catabolic process (GO:0000272) | 3.10263876 |
| 90 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.09401890 |
| 91 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.08946520 |
| 92 | fructose metabolic process (GO:0006000) | 3.04633351 |
| 93 | intestinal cholesterol absorption (GO:0030299) | 3.01777028 |
| 94 | glutamate metabolic process (GO:0006536) | 2.98982639 |
| 95 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.97874514 |
| 96 | L-phenylalanine catabolic process (GO:0006559) | 2.97874514 |
| 97 | cell communication involved in cardiac conduction (GO:0086065) | 2.97638168 |
| 98 | regulation of plasminogen activation (GO:0010755) | 2.96746388 |
| 99 | regulation of synapse structural plasticity (GO:0051823) | 2.96506266 |
| 100 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.95665910 |
| 101 | neuromuscular junction development (GO:0007528) | 2.95106326 |
| 102 | muscle atrophy (GO:0014889) | 2.94463816 |
| 103 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.93875835 |
| 104 | locomotory exploration behavior (GO:0035641) | 2.93128492 |
| 105 | response to muscle activity (GO:0014850) | 2.92561251 |
| 106 | skeletal muscle tissue regeneration (GO:0043403) | 2.91562099 |
| 107 | detection of calcium ion (GO:0005513) | 2.91062457 |
| 108 | epoxygenase P450 pathway (GO:0019373) | 2.90534285 |
| 109 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.90533946 |
| 110 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.87048864 |
| 111 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.86015159 |
| 112 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.86015159 |
| 113 | vocalization behavior (GO:0071625) | 2.85848236 |
| 114 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.85798343 |
| 115 | glyoxylate metabolic process (GO:0046487) | 2.85758359 |
| 116 | ethanol oxidation (GO:0006069) | 2.85169476 |
| 117 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.83463888 |
| 118 | 2-oxoglutarate metabolic process (GO:0006103) | 2.83414505 |
| 119 | plasma lipoprotein particle clearance (GO:0034381) | 2.82334192 |
| 120 | phospholipid homeostasis (GO:0055091) | 2.81292631 |
| 121 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.80565737 |
| 122 | L-phenylalanine metabolic process (GO:0006558) | 2.80565737 |
| 123 | synaptic vesicle exocytosis (GO:0016079) | 2.80051056 |
| 124 | cardiac muscle cell development (GO:0055013) | 2.79502479 |
| 125 | striated muscle hypertrophy (GO:0014897) | 2.78767356 |
| 126 | regulation of cholesterol homeostasis (GO:2000188) | 2.77807530 |
| 127 | acylglycerol homeostasis (GO:0055090) | 2.75947319 |
| 128 | triglyceride homeostasis (GO:0070328) | 2.75947319 |
| 129 | striated muscle cell development (GO:0055002) | 2.75249838 |
| 130 | glycogen biosynthetic process (GO:0005978) | 2.74501764 |
| 131 | glucan biosynthetic process (GO:0009250) | 2.74501764 |
| 132 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.73785895 |
| 133 | fibrinolysis (GO:0042730) | 2.73768126 |
| 134 | cardiac muscle hypertrophy (GO:0003300) | 2.72892121 |
| 135 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.72071906 |
| 136 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.72047061 |
| 137 | regulation of apoptotic cell clearance (GO:2000425) | 2.71184004 |
| 138 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.69544788 |
| 139 | negative regulation of muscle hypertrophy (GO:0014741) | 2.69401225 |
| 140 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.69378972 |
| 141 | myotube differentiation (GO:0014902) | 2.66598621 |
| 142 | muscle adaptation (GO:0043500) | 2.66015602 |
| 143 | activation of protein kinase A activity (GO:0034199) | 2.65972970 |
| 144 | cardiac muscle cell action potential (GO:0086001) | 2.65372035 |
| 145 | positive regulation of myoblast differentiation (GO:0045663) | 2.64973543 |
| 146 | potassium ion import (GO:0010107) | 2.64744674 |
| 147 | tricarboxylic acid cycle (GO:0006099) | 2.62986710 |
| 148 | glutamate secretion (GO:0014047) | 2.62857040 |
| 149 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.62764759 |
| 150 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.62142169 |
| 151 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.62029093 |
| 152 | response to mercury ion (GO:0046689) | 2.60516006 |
| 153 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.60394232 |
| 154 | negative regulation of protein activation cascade (GO:2000258) | 2.58652198 |
| 155 | COPII vesicle coating (GO:0048208) | 2.57651062 |
| 156 | paraxial mesoderm development (GO:0048339) | 2.57500748 |
| 157 | negative regulation of protein localization to cell surface (GO:2000009) | 2.57007799 |
| 158 | exogenous drug catabolic process (GO:0042738) | 2.54868590 |
| 159 | gluconeogenesis (GO:0006094) | 2.54817272 |
| 160 | intestinal absorption (GO:0050892) | 2.53383674 |
| 161 | cellular glucuronidation (GO:0052695) | 2.53354731 |
| 162 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.52282933 |
| 163 | negative regulation of hemostasis (GO:1900047) | 2.50660586 |
| 164 | negative regulation of blood coagulation (GO:0030195) | 2.50660586 |
| 165 | 4-hydroxyproline metabolic process (GO:0019471) | 2.49150161 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.87249801 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.75683540 |
| 3 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.38115774 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.50224083 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.48413533 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.47261054 |
| 7 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.47234122 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.44393613 |
| 9 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.41843876 |
| 10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.38237489 |
| 11 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.32717388 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.31737299 |
| 13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.28865083 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.27745698 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.23397352 |
| 16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.22728026 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.22728026 |
| 18 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.20234640 |
| 19 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.18437960 |
| 20 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.18160466 |
| 21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.17166762 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.16772296 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.13313261 |
| 24 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.06806978 |
| 25 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.06061217 |
| 26 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.03284936 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.02899320 |
| 28 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.02224498 |
| 29 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.99608734 |
| 30 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.99438064 |
| 31 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.97239440 |
| 32 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.95408581 |
| 33 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.95123795 |
| 34 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.92316198 |
| 35 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.87550503 |
| 36 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.82223156 |
| 37 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.81555467 |
| 38 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.79659761 |
| 39 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.73113895 |
| 40 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.72972128 |
| 41 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.72733881 |
| 42 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.72386508 |
| 43 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.67782154 |
| 44 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.63621933 |
| 45 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.61891028 |
| 46 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.61543899 |
| 47 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60947487 |
| 48 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.55332989 |
| 49 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.53690946 |
| 50 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.52007996 |
| 51 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.51576634 |
| 52 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.49401571 |
| 53 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.47423949 |
| 54 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.46037229 |
| 55 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.45727357 |
| 56 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.42878521 |
| 57 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.42851847 |
| 58 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.41313348 |
| 59 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.39894414 |
| 60 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.39848398 |
| 61 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.39335998 |
| 62 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.38548100 |
| 63 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35863224 |
| 64 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.35420428 |
| 65 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.33370944 |
| 66 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.32654041 |
| 67 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.31934431 |
| 68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27430035 |
| 69 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.25854661 |
| 70 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.25854661 |
| 71 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.25181864 |
| 72 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24930955 |
| 73 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.24278318 |
| 74 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.23830851 |
| 75 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.23161249 |
| 76 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.22066422 |
| 77 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.21538721 |
| 78 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21000025 |
| 79 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20859298 |
| 80 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.20384662 |
| 81 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.20085981 |
| 82 | AR_19668381_ChIP-Seq_PC3_Human | 1.19638169 |
| 83 | AR_25329375_ChIP-Seq_VCAP_Human | 1.18973415 |
| 84 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18634950 |
| 85 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18335509 |
| 86 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.17863353 |
| 87 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16841381 |
| 88 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.16370539 |
| 89 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.16210592 |
| 90 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15881169 |
| 91 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15169934 |
| 92 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.14201273 |
| 93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13449094 |
| 94 | FUS_26573619_Chip-Seq_HEK293_Human | 1.12886253 |
| 95 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.10578039 |
| 96 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.10346309 |
| 97 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.09524756 |
| 98 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.07952433 |
| 99 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.07296834 |
| 100 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05631005 |
| 101 | STAT3_23295773_ChIP-Seq_U87_Human | 1.05592499 |
| 102 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.05355167 |
| 103 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04971332 |
| 104 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04535152 |
| 105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04521847 |
| 106 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.04518739 |
| 107 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.04503685 |
| 108 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04400220 |
| 109 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.04357601 |
| 110 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.04092654 |
| 111 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.04066068 |
| 112 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03934203 |
| 113 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.03791686 |
| 114 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03635886 |
| 115 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.03529295 |
| 116 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.03131156 |
| 117 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02737442 |
| 118 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02648625 |
| 119 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02149728 |
| 120 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02129150 |
| 121 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01859151 |
| 122 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.01826103 |
| 123 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.01779424 |
| 124 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.01723564 |
| 125 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01395092 |
| 126 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01134105 |
| 127 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99274372 |
| 128 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98945227 |
| 129 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.98914720 |
| 130 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.98864136 |
| 131 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.98644642 |
| 132 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.98399706 |
| 133 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.98399706 |
| 134 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98309201 |
| 135 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98227249 |
| 136 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98099058 |
| 137 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98069008 |
| 138 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.97687360 |
| 139 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.97622702 |
| 140 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.97084734 |
| 141 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.97057215 |
| 142 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96547006 |
| 143 | P300_19829295_ChIP-Seq_ESCs_Human | 0.96436886 |
| 144 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.95542850 |
| 145 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.94505685 |
| 146 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.94290560 |
| 147 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.93876937 |
| 148 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.93662797 |
| 149 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.92318782 |
| 150 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.91812141 |
| 151 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.91483544 |
| 152 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91259364 |
| 153 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91259364 |
| 154 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.91083887 |
| 155 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.91053811 |
| 156 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.90668969 |
| 157 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88790334 |
| 158 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.88706343 |
| 159 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.88585688 |
| 160 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88343992 |
| 161 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88138428 |
| 162 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.88035203 |
| 163 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.87003566 |
| 164 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.86909672 |
| 165 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.86887068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 6.12287609 |
| 2 | MP0000751_myopathy | 4.94351677 |
| 3 | MP0000749_muscle_degeneration | 4.78270351 |
| 4 | MP0003646_muscle_fatigue | 4.63307074 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.75258260 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.51895141 |
| 7 | MP0000747_muscle_weakness | 3.22871003 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 3.19982502 |
| 9 | MP0002106_abnormal_muscle_physiology | 3.15468658 |
| 10 | MP0004859_abnormal_synaptic_plasticity | 3.07137023 |
| 11 | MP0004270_analgesia | 2.82436597 |
| 12 | MP0004087_abnormal_muscle_fiber | 2.80302148 |
| 13 | MP0000759_abnormal_skeletal_muscle | 2.78917282 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.75030199 |
| 15 | MP0002269_muscular_atrophy | 2.75009439 |
| 16 | MP0004130_abnormal_muscle_cell | 2.69276670 |
| 17 | MP0005369_muscle_phenotype | 2.68350263 |
| 18 | MP0003941_abnormal_skin_development | 2.60689659 |
| 19 | MP0004233_abnormal_muscle_weight | 2.48701752 |
| 20 | MP0004084_abnormal_cardiac_muscle | 2.44352105 |
| 21 | MP0000750_abnormal_muscle_regeneration | 2.43521496 |
| 22 | MP0005085_abnormal_gallbladder_physiolo | 2.36950940 |
| 23 | MP0005360_urolithiasis | 2.36414451 |
| 24 | MP0004215_abnormal_myocardial_fiber | 2.28140513 |
| 25 | MP0005365_abnormal_bile_salt | 2.25962934 |
| 26 | MP0004272_abnormal_basement_membrane | 2.19380615 |
| 27 | MP0003122_maternal_imprinting | 2.18383819 |
| 28 | MP0005451_abnormal_body_composition | 2.08654907 |
| 29 | MP0005330_cardiomyopathy | 2.05944757 |
| 30 | MP0010329_abnormal_lipoprotein_level | 2.02647053 |
| 31 | MP0003195_calcinosis | 1.98506062 |
| 32 | MP0001666_abnormal_nutrient_absorption | 1.89383944 |
| 33 | MP0003635_abnormal_synaptic_transmissio | 1.85297416 |
| 34 | MP0003890_abnormal_embryonic-extraembry | 1.79952675 |
| 35 | MP0002972_abnormal_cardiac_muscle | 1.74776492 |
| 36 | MP0004484_altered_response_of | 1.73230472 |
| 37 | MP0002108_abnormal_muscle_morphology | 1.71203075 |
| 38 | MP0003880_abnormal_central_pattern | 1.65336549 |
| 39 | MP0009697_abnormal_copulation | 1.56119345 |
| 40 | MP0003137_abnormal_impulse_conducting | 1.53574414 |
| 41 | MP0002332_abnormal_exercise_endurance | 1.50359689 |
| 42 | MP0002734_abnormal_mechanical_nocicepti | 1.47947231 |
| 43 | MP0009046_muscle_twitch | 1.43184305 |
| 44 | MP0003868_abnormal_feces_composition | 1.42403244 |
| 45 | MP0002063_abnormal_learning/memory/cond | 1.39242040 |
| 46 | MP0000013_abnormal_adipose_tissue | 1.38683434 |
| 47 | MP0009745_abnormal_behavioral_response | 1.37445805 |
| 48 | MP0001661_extended_life_span | 1.36287316 |
| 49 | MP0009780_abnormal_chondrocyte_physiolo | 1.34786302 |
| 50 | MP0000733_abnormal_muscle_development | 1.33676868 |
| 51 | MP0009840_abnormal_foam_cell | 1.27978958 |
| 52 | MP0010630_abnormal_cardiac_muscle | 1.27451399 |
| 53 | MP0001968_abnormal_touch/_nociception | 1.26398390 |
| 54 | MP0004085_abnormal_heartbeat | 1.23885999 |
| 55 | MP0005409_darkened_coat_color | 1.23804297 |
| 56 | MP0010368_abnormal_lymphatic_system | 1.22697592 |
| 57 | MP0002064_seizures | 1.21657320 |
| 58 | MP0001915_intracranial_hemorrhage | 1.21207227 |
| 59 | MP0004858_abnormal_nervous_system | 1.16587297 |
| 60 | MP0009672_abnormal_birth_weight | 1.15899360 |
| 61 | MP0008569_lethality_at_weaning | 1.15808153 |
| 62 | MP0005385_cardiovascular_system_phenoty | 1.14641557 |
| 63 | MP0001544_abnormal_cardiovascular_syste | 1.14641557 |
| 64 | MP0002909_abnormal_adrenal_gland | 1.14638740 |
| 65 | MP0002735_abnormal_chemical_nociception | 1.14494757 |
| 66 | MP0008775_abnormal_heart_ventricle | 1.13842492 |
| 67 | MP0001440_abnormal_grooming_behavior | 1.13829532 |
| 68 | MP0004510_myositis | 1.12891691 |
| 69 | MP0003385_abnormal_body_wall | 1.10488178 |
| 70 | MP0003123_paternal_imprinting | 1.09469575 |
| 71 | MP0008438_abnormal_cutaneous_collagen | 1.07835020 |
| 72 | MP0003252_abnormal_bile_duct | 1.07727579 |
| 73 | MP0002272_abnormal_nervous_system | 1.07370630 |
| 74 | MP0006036_abnormal_mitochondrial_physio | 1.06405860 |
| 75 | MP0002067_abnormal_sensory_capabilities | 1.05480108 |
| 76 | MP0003566_abnormal_cell_adhesion | 1.04508610 |
| 77 | MP0005332_abnormal_amino_acid | 1.02280201 |
| 78 | MP0001299_abnormal_eye_distance/ | 1.01560980 |
| 79 | MP0004185_abnormal_adipocyte_glucose | 1.01136189 |
| 80 | MP0002572_abnormal_emotion/affect_behav | 1.00581010 |
| 81 | MP0003567_abnormal_fetal_cardiomyocyte | 0.99481416 |
| 82 | MP0002184_abnormal_innervation | 0.99225241 |
| 83 | MP0003221_abnormal_cardiomyocyte_apopto | 0.97635604 |
| 84 | MP0001486_abnormal_startle_reflex | 0.97139367 |
| 85 | MP0008961_abnormal_basal_metabolism | 0.95933529 |
| 86 | MP0005423_abnormal_somatic_nervous | 0.92679817 |
| 87 | MP0002697_abnormal_eye_size | 0.92182076 |
| 88 | MP0002127_abnormal_cardiovascular_syste | 0.90655319 |
| 89 | MP0002234_abnormal_pharynx_morphology | 0.90435812 |
| 90 | MP0009384_cardiac_valve_regurgitation | 0.90224968 |
| 91 | MP0002089_abnormal_postnatal_growth/wei | 0.90048401 |
| 92 | MP0002822_catalepsy | 0.89535133 |
| 93 | MP0002736_abnormal_nociception_after | 0.89226945 |
| 94 | MP0003705_abnormal_hypodermis_morpholog | 0.88638160 |
| 95 | MP0002733_abnormal_thermal_nociception | 0.85649630 |
| 96 | MP0006035_abnormal_mitochondrial_morpho | 0.85348722 |
| 97 | MP0001501_abnormal_sleep_pattern | 0.85203184 |
| 98 | MP0006138_congestive_heart_failure | 0.85024957 |
| 99 | MP0003329_amyloid_beta_deposits | 0.84011065 |
| 100 | MP0005623_abnormal_meninges_morphology | 0.83965780 |
| 101 | MP0000566_synostosis | 0.82847895 |
| 102 | MP0000955_abnormal_spinal_cord | 0.82361072 |
| 103 | MP0004924_abnormal_behavior | 0.81556241 |
| 104 | MP0005386_behavior/neurological_phenoty | 0.81556241 |
| 105 | MP0005666_abnormal_adipose_tissue | 0.81498615 |
| 106 | MP0002233_abnormal_nose_morphology | 0.80261344 |
| 107 | MP0004811_abnormal_neuron_physiology | 0.79426458 |
| 108 | MP0000762_abnormal_tongue_morphology | 0.79124803 |
| 109 | MP0002066_abnormal_motor_capabilities/c | 0.77423391 |
| 110 | MP0000534_abnormal_ureter_morphology | 0.76934370 |
| 111 | MP0001970_abnormal_pain_threshold | 0.76641852 |
| 112 | MP0005375_adipose_tissue_phenotype | 0.76411542 |
| 113 | MP0010030_abnormal_orbit_morphology | 0.73837139 |
| 114 | MP0009703_decreased_birth_body | 0.73426578 |
| 115 | MP0003937_abnormal_limbs/digits/tail_de | 0.73038366 |
| 116 | MP0003950_abnormal_plasma_membrane | 0.72446578 |
| 117 | MP0005670_abnormal_white_adipose | 0.72032123 |
| 118 | MP0006276_abnormal_autonomic_nervous | 0.71796266 |
| 119 | MP0004142_abnormal_muscle_tone | 0.71386310 |
| 120 | MP0004043_abnormal_pH_regulation | 0.71166887 |
| 121 | MP0003045_fibrosis | 0.71012339 |
| 122 | MP0002128_abnormal_blood_circulation | 0.70472054 |
| 123 | MP0002118_abnormal_lipid_homeostasis | 0.69586424 |
| 124 | MP0008875_abnormal_xenobiotic_pharmacok | 0.69053581 |
| 125 | MP0001730_embryonic_growth_arrest | 0.68957780 |
| 126 | MP0004197_abnormal_fetal_growth/weight/ | 0.68773176 |
| 127 | MP0003984_embryonic_growth_retardation | 0.68723658 |
| 128 | MP0000003_abnormal_adipose_tissue | 0.68035947 |
| 129 | MP0003119_abnormal_digestive_system | 0.67549159 |
| 130 | MP0002971_abnormal_brown_adipose | 0.67498609 |
| 131 | MP0002084_abnormal_developmental_patter | 0.66668970 |
| 132 | MP0002088_abnormal_embryonic_growth/wei | 0.65920844 |
| 133 | MP0002882_abnormal_neuron_morphology | 0.65526372 |
| 134 | MP0001529_abnormal_vocalization | 0.64780273 |
| 135 | MP0000778_abnormal_nervous_system | 0.64010926 |
| 136 | MP0003942_abnormal_urinary_system | 0.63726751 |
| 137 | MP0003121_genomic_imprinting | 0.62891291 |
| 138 | MP0003935_abnormal_craniofacial_develop | 0.62738052 |
| 139 | MP0000462_abnormal_digestive_system | 0.61141477 |
| 140 | MP0000428_abnormal_craniofacial_morphol | 0.60363257 |
| 141 | MP0005380_embryogenesis_phenotype | 0.60050083 |
| 142 | MP0001672_abnormal_embryogenesis/_devel | 0.60050083 |
| 143 | MP0000266_abnormal_heart_morphology | 0.59174981 |
| 144 | MP0003879_abnormal_hair_cell | 0.57678439 |
| 145 | MP0002557_abnormal_social/conspecific_i | 0.56932326 |
| 146 | MP0005187_abnormal_penis_morphology | 0.52855191 |
| 147 | MP0003828_pulmonary_edema | 0.52759715 |
| 148 | MP0005275_abnormal_skin_tensile | 0.51928510 |
| 149 | MP0003283_abnormal_digestive_organ | 0.51561149 |
| 150 | MP0003633_abnormal_nervous_system | 0.51278401 |
| 151 | MP0009250_abnormal_appendicular_skeleto | 0.50713073 |
| 152 | MP0004134_abnormal_chest_morphology | 0.49136257 |
| 153 | MP0005503_abnormal_tendon_morphology | 0.48829962 |
| 154 | MP0005535_abnormal_body_temperature | 0.48571075 |
| 155 | MP0000230_abnormal_systemic_arterial | 0.47429256 |
| 156 | MP0001943_abnormal_respiration | 0.46529909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 7.76810727 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 7.17143030 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.98629477 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 6.93215015 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.56438774 |
| 6 | Nemaline bodies (HP:0003798) | 6.32524501 |
| 7 | Calf muscle hypertrophy (HP:0008981) | 6.06518462 |
| 8 | Distal arthrogryposis (HP:0005684) | 5.55017988 |
| 9 | Type 1 muscle fiber predominance (HP:0003803) | 5.44606616 |
| 10 | Deep venous thrombosis (HP:0002625) | 5.11029045 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 5.06278986 |
| 12 | Difficulty running (HP:0009046) | 4.99800101 |
| 13 | Myopathic facies (HP:0002058) | 4.82388000 |
| 14 | Muscle fiber splitting (HP:0003555) | 4.80999267 |
| 15 | Round ear (HP:0100830) | 4.71194710 |
| 16 | Abnormality of the calf musculature (HP:0001430) | 4.65630394 |
| 17 | Myoglobinuria (HP:0002913) | 4.50882578 |
| 18 | EMG: myopathic abnormalities (HP:0003458) | 4.41318288 |
| 19 | Myotonia (HP:0002486) | 4.28087722 |
| 20 | Prolonged partial thromboplastin time (HP:0003645) | 4.24819235 |
| 21 | Ulnar deviation of the wrist (HP:0003049) | 4.18047126 |
| 22 | Muscle stiffness (HP:0003552) | 4.07417703 |
| 23 | Sudden death (HP:0001699) | 4.06766552 |
| 24 | Hypobetalipoproteinemia (HP:0003563) | 3.88371321 |
| 25 | Increased connective tissue (HP:0009025) | 3.76445587 |
| 26 | Absent phalangeal crease (HP:0006109) | 3.64017237 |
| 27 | Calcaneovalgus deformity (HP:0001848) | 3.44741828 |
| 28 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.43969628 |
| 29 | Subaortic stenosis (HP:0001682) | 3.43969628 |
| 30 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.40449354 |
| 31 | Increased variability in muscle fiber diameter (HP:0003557) | 3.35054425 |
| 32 | Hypolipoproteinemia (HP:0010981) | 3.33226650 |
| 33 | Difficulty climbing stairs (HP:0003551) | 3.32029144 |
| 34 | Rhabdomyolysis (HP:0003201) | 3.31464361 |
| 35 | Deformed tarsal bones (HP:0008119) | 3.17224482 |
| 36 | Abnormality of the common coagulation pathway (HP:0010990) | 3.11460317 |
| 37 | Rimmed vacuoles (HP:0003805) | 3.09382098 |
| 38 | Abnormal finger flexion creases (HP:0006143) | 3.08191997 |
| 39 | Shoulder girdle muscle weakness (HP:0003547) | 2.99891328 |
| 40 | Hypoalphalipoproteinemia (HP:0003233) | 2.97432649 |
| 41 | Joint hemorrhage (HP:0005261) | 2.96824911 |
| 42 | Areflexia of lower limbs (HP:0002522) | 2.94768705 |
| 43 | Neck muscle weakness (HP:0000467) | 2.90375434 |
| 44 | Complement deficiency (HP:0004431) | 2.83824727 |
| 45 | Pelvic girdle muscle weakness (HP:0003749) | 2.80128025 |
| 46 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.79513673 |
| 47 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.79513673 |
| 48 | Focal motor seizures (HP:0011153) | 2.78232007 |
| 49 | Asymmetric septal hypertrophy (HP:0001670) | 2.77092637 |
| 50 | Hyperkalemia (HP:0002153) | 2.75800776 |
| 51 | Distal lower limb muscle weakness (HP:0009053) | 2.65625941 |
| 52 | Malignant hyperthermia (HP:0002047) | 2.61494251 |
| 53 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.59919929 |
| 54 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.55238964 |
| 55 | Frequent falls (HP:0002359) | 2.49486021 |
| 56 | EMG: neuropathic changes (HP:0003445) | 2.48583844 |
| 57 | Ventricular tachycardia (HP:0004756) | 2.47995403 |
| 58 | Muscular dystrophy (HP:0003560) | 2.46432213 |
| 59 | Bundle branch block (HP:0011710) | 2.39236152 |
| 60 | Visual hallucinations (HP:0002367) | 2.36477452 |
| 61 | Hepatoblastoma (HP:0002884) | 2.36211545 |
| 62 | Hypercholesterolemia (HP:0003124) | 2.31341467 |
| 63 | Distal lower limb amyotrophy (HP:0008944) | 2.31306416 |
| 64 | Papillary thyroid carcinoma (HP:0002895) | 2.27899791 |
| 65 | Lower limb amyotrophy (HP:0007210) | 2.27343581 |
| 66 | Xanthomatosis (HP:0000991) | 2.26878493 |
| 67 | Increased serum pyruvate (HP:0003542) | 2.25845683 |
| 68 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.25513892 |
| 69 | Atrial fibrillation (HP:0005110) | 2.25093034 |
| 70 | Spontaneous abortion (HP:0005268) | 2.23151670 |
| 71 | Abnormality of the neuromuscular junction (HP:0003398) | 2.22283084 |
| 72 | Fatigable weakness (HP:0003473) | 2.22283084 |
| 73 | Prolonged QT interval (HP:0001657) | 2.21138852 |
| 74 | Fetal akinesia sequence (HP:0001989) | 2.19809548 |
| 75 | Proximal amyotrophy (HP:0007126) | 2.18243484 |
| 76 | Primary atrial arrhythmia (HP:0001692) | 2.17357380 |
| 77 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.17156891 |
| 78 | Acanthocytosis (HP:0001927) | 2.16343609 |
| 79 | Gowers sign (HP:0003391) | 2.14557642 |
| 80 | Limb-girdle muscle atrophy (HP:0003797) | 2.14454619 |
| 81 | Scapular winging (HP:0003691) | 2.10530682 |
| 82 | Limb-girdle muscle weakness (HP:0003325) | 2.08894345 |
| 83 | Hypoplastic ischia (HP:0003175) | 2.08031977 |
| 84 | Supraventricular tachycardia (HP:0004755) | 2.04417298 |
| 85 | Broad-based gait (HP:0002136) | 2.04006664 |
| 86 | Focal seizures (HP:0007359) | 2.03173849 |
| 87 | Abnormality of glycolysis (HP:0004366) | 2.03139146 |
| 88 | Lipoatrophy (HP:0100578) | 2.00310842 |
| 89 | Supraventricular arrhythmia (HP:0005115) | 1.99941153 |
| 90 | Abnormality of the calcaneus (HP:0008364) | 1.99856165 |
| 91 | Facial diplegia (HP:0001349) | 1.99764567 |
| 92 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.99332246 |
| 93 | Abnormality of complement system (HP:0005339) | 1.96387257 |
| 94 | Slender build (HP:0001533) | 1.95732458 |
| 95 | Foot dorsiflexor weakness (HP:0009027) | 1.92597859 |
| 96 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.92210783 |
| 97 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.91026824 |
| 98 | Syncope (HP:0001279) | 1.90832261 |
| 99 | Hyperlipoproteinemia (HP:0010980) | 1.89382002 |
| 100 | Ventricular arrhythmia (HP:0004308) | 1.89327734 |
| 101 | Myokymia (HP:0002411) | 1.89165241 |
| 102 | Popliteal pterygium (HP:0009756) | 1.88933101 |
| 103 | Intrahepatic cholestasis (HP:0001406) | 1.88495421 |
| 104 | Pheochromocytoma (HP:0002666) | 1.87918149 |
| 105 | Right ventricular cardiomyopathy (HP:0011663) | 1.86381355 |
| 106 | Generalized muscle weakness (HP:0003324) | 1.86298103 |
| 107 | Abnormality of the foot musculature (HP:0001436) | 1.85665990 |
| 108 | Abnormality of the ischium (HP:0003174) | 1.84729782 |
| 109 | Atonic seizures (HP:0010819) | 1.83705282 |
| 110 | Back pain (HP:0003418) | 1.83695915 |
| 111 | Abnormality of the intrinsic pathway (HP:0010989) | 1.82786693 |
| 112 | Limited hip movement (HP:0008800) | 1.81865471 |
| 113 | Steppage gait (HP:0003376) | 1.81108182 |
| 114 | Spinal rigidity (HP:0003306) | 1.80977330 |
| 115 | Mitral stenosis (HP:0001718) | 1.80846763 |
| 116 | Nonprogressive disorder (HP:0003680) | 1.79796180 |
| 117 | Abnormal EKG (HP:0003115) | 1.78265233 |
| 118 | Urinary urgency (HP:0000012) | 1.75953967 |
| 119 | Ventricular fibrillation (HP:0001663) | 1.75252732 |
| 120 | Epidermoid cyst (HP:0200040) | 1.74127181 |
| 121 | Heart block (HP:0012722) | 1.73919086 |
| 122 | Ulnar deviation of finger (HP:0009465) | 1.73828099 |
| 123 | Bulbar palsy (HP:0001283) | 1.73379414 |
| 124 | Pterygium (HP:0001059) | 1.73016839 |
| 125 | Dilated cardiomyopathy (HP:0001644) | 1.71341286 |
| 126 | Febrile seizures (HP:0002373) | 1.70914502 |
| 127 | Hyperglycinuria (HP:0003108) | 1.70233963 |
| 128 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.70141983 |
| 129 | Achilles tendon contracture (HP:0001771) | 1.69565893 |
| 130 | Palpitations (HP:0001962) | 1.68973615 |
| 131 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.66260107 |
| 132 | Impaired pain sensation (HP:0007328) | 1.65310556 |
| 133 | Abnormality of pain sensation (HP:0010832) | 1.65310556 |
| 134 | Vascular calcification (HP:0004934) | 1.64797731 |
| 135 | Menorrhagia (HP:0000132) | 1.63192774 |
| 136 | Gout (HP:0001997) | 1.60515338 |
| 137 | Protrusio acetabuli (HP:0003179) | 1.57651711 |
| 138 | Cardiovascular calcification (HP:0011915) | 1.56973319 |
| 139 | Proximal tubulopathy (HP:0000114) | 1.55820276 |
| 140 | Abnormal delivery (HP:0001787) | 1.55546867 |
| 141 | Osteomalacia (HP:0002749) | 1.54241954 |
| 142 | Asymmetry of the thorax (HP:0001555) | 1.53698234 |
| 143 | Glomerulonephritis (HP:0000099) | 1.53488568 |
| 144 | Fat malabsorption (HP:0002630) | 1.50936435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 5.79669036 |
| 2 | PHKG2 | 4.91784788 |
| 3 | PHKG1 | 4.91784788 |
| 4 | TTN | 4.63651662 |
| 5 | NME1 | 2.99441385 |
| 6 | LATS1 | 2.78690007 |
| 7 | FGFR4 | 2.32319118 |
| 8 | DMPK | 2.30781067 |
| 9 | MAP3K9 | 2.19417444 |
| 10 | NTRK3 | 2.15732207 |
| 11 | MAP2K4 | 1.98670139 |
| 12 | PDK3 | 1.97731927 |
| 13 | PDK4 | 1.97731927 |
| 14 | FGFR3 | 1.92794749 |
| 15 | EEF2K | 1.86845772 |
| 16 | NEK1 | 1.78182945 |
| 17 | EPHA4 | 1.76083742 |
| 18 | MARK1 | 1.74187312 |
| 19 | PIK3CA | 1.67659868 |
| 20 | PINK1 | 1.65896980 |
| 21 | PIK3CG | 1.58584435 |
| 22 | MAP3K7 | 1.58290800 |
| 23 | MAP3K4 | 1.57864598 |
| 24 | MUSK | 1.50371809 |
| 25 | BCR | 1.50128545 |
| 26 | BRD4 | 1.49877892 |
| 27 | MINK1 | 1.49787179 |
| 28 | KSR2 | 1.36022432 |
| 29 | MAP2K3 | 1.33201444 |
| 30 | FGFR1 | 1.32622080 |
| 31 | TNIK | 1.31272158 |
| 32 | TAOK2 | 1.27427689 |
| 33 | MAPK12 | 1.23159583 |
| 34 | ICK | 1.22239599 |
| 35 | PAK6 | 1.20780167 |
| 36 | TRIB3 | 1.15295687 |
| 37 | LMTK2 | 1.15003003 |
| 38 | MAP3K10 | 1.05291024 |
| 39 | FGFR2 | 1.05029482 |
| 40 | DAPK2 | 1.04896190 |
| 41 | PDK2 | 1.04382627 |
| 42 | NEK9 | 1.03730686 |
| 43 | WNK3 | 1.02865628 |
| 44 | LATS2 | 1.02840228 |
| 45 | CDK12 | 1.01173251 |
| 46 | PRKD3 | 0.97431999 |
| 47 | DYRK1B | 0.95495853 |
| 48 | TYRO3 | 0.95112668 |
| 49 | MET | 0.95027185 |
| 50 | MAP2K6 | 0.93178835 |
| 51 | KSR1 | 0.93152743 |
| 52 | PLK2 | 0.88373661 |
| 53 | PNCK | 0.87291022 |
| 54 | PTK2B | 0.86956624 |
| 55 | STK24 | 0.85598023 |
| 56 | MAP2K7 | 0.84147360 |
| 57 | MAPKAPK3 | 0.83266891 |
| 58 | ERBB3 | 0.83183887 |
| 59 | STK38 | 0.82334869 |
| 60 | NTRK1 | 0.82040625 |
| 61 | PBK | 0.79128235 |
| 62 | MAPK13 | 0.78515507 |
| 63 | MYLK | 0.77363723 |
| 64 | RPS6KB1 | 0.76774778 |
| 65 | WNK1 | 0.74935556 |
| 66 | CAMKK1 | 0.74728890 |
| 67 | EPHA3 | 0.72797077 |
| 68 | SGK1 | 0.71970069 |
| 69 | PRKAA1 | 0.71704432 |
| 70 | RET | 0.71454459 |
| 71 | ERBB4 | 0.69719329 |
| 72 | CAMK1G | 0.66442962 |
| 73 | ACVR1B | 0.66240346 |
| 74 | CAMK2A | 0.64978059 |
| 75 | DDR2 | 0.64970999 |
| 76 | MAP3K2 | 0.63261119 |
| 77 | PAK3 | 0.63045649 |
| 78 | RIPK1 | 0.63000082 |
| 79 | CDK5 | 0.62942219 |
| 80 | LIMK1 | 0.62422285 |
| 81 | TAOK1 | 0.62370278 |
| 82 | CAMK2D | 0.61416797 |
| 83 | MAP3K12 | 0.60946347 |
| 84 | MAP3K1 | 0.60525895 |
| 85 | GRK5 | 0.60426086 |
| 86 | ROCK1 | 0.59744339 |
| 87 | NTRK2 | 0.57888690 |
| 88 | CAMK2G | 0.57416235 |
| 89 | RIPK4 | 0.57412150 |
| 90 | TTK | 0.56736650 |
| 91 | SGK2 | 0.56326564 |
| 92 | CAMKK2 | 0.55378019 |
| 93 | SGK3 | 0.55334937 |
| 94 | CSNK1E | 0.55265448 |
| 95 | PRKAA2 | 0.54711440 |
| 96 | CDC42BPA | 0.54356425 |
| 97 | STK38L | 0.54066610 |
| 98 | STK3 | 0.53212149 |
| 99 | CASK | 0.51549758 |
| 100 | RPS6KA2 | 0.51379312 |
| 101 | MTOR | 0.50895406 |
| 102 | PKN2 | 0.49182663 |
| 103 | FER | 0.48707173 |
| 104 | PDGFRB | 0.48240762 |
| 105 | EIF2AK3 | 0.47615368 |
| 106 | ERBB2 | 0.46652505 |
| 107 | RPS6KA3 | 0.45412734 |
| 108 | MAP2K1 | 0.45335741 |
| 109 | CAMK1 | 0.45301585 |
| 110 | SGK494 | 0.45231567 |
| 111 | SGK223 | 0.45231567 |
| 112 | PRKG1 | 0.44353324 |
| 113 | STK11 | 0.44311633 |
| 114 | PKN1 | 0.43049627 |
| 115 | PDPK1 | 0.42138287 |
| 116 | CAMK4 | 0.41899032 |
| 117 | MAP3K5 | 0.41744411 |
| 118 | PDK1 | 0.40860872 |
| 119 | FLT3 | 0.40150362 |
| 120 | PRKCH | 0.39768760 |
| 121 | PRKACG | 0.39340285 |
| 122 | ZAK | 0.39269005 |
| 123 | MAP3K6 | 0.38829516 |
| 124 | PRKACB | 0.38473881 |
| 125 | ILK | 0.38120537 |
| 126 | PRKG2 | 0.37999346 |
| 127 | YES1 | 0.35713416 |
| 128 | TRIM28 | 0.35698937 |
| 129 | PRKCG | 0.35417967 |
| 130 | TRPM7 | 0.34657141 |
| 131 | MAPK11 | 0.34607727 |
| 132 | PRKACA | 0.34547779 |
| 133 | DYRK1A | 0.34347100 |
| 134 | CSNK1D | 0.34328799 |
| 135 | PRKD1 | 0.33450251 |
| 136 | PDGFRA | 0.33118637 |
| 137 | AKT3 | 0.32654370 |
| 138 | ROCK2 | 0.31795739 |
| 139 | MAPK10 | 0.31233129 |
| 140 | SIK2 | 0.28447935 |
| 141 | AKT2 | 0.27960969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.04131570 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.83622463 |
| 3 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.80526345 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.78538751 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.57344162 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.54250195 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.35618920 |
| 8 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.25170515 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.15587123 |
| 10 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.14274822 |
| 11 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.10092508 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.07999745 |
| 13 | Circadian entrainment_Homo sapiens_hsa04713 | 1.97751612 |
| 14 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.93834233 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.93592659 |
| 16 | Long-term potentiation_Homo sapiens_hsa04720 | 1.90327892 |
| 17 | Nicotine addiction_Homo sapiens_hsa05033 | 1.89789650 |
| 18 | Olfactory transduction_Homo sapiens_hsa04740 | 1.75526175 |
| 19 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.73432981 |
| 20 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.71217232 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.70193419 |
| 22 | Insulin secretion_Homo sapiens_hsa04911 | 1.69412616 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.62382222 |
| 24 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.62246427 |
| 25 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.60293929 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.59893999 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.58704710 |
| 28 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.57686609 |
| 29 | Renin secretion_Homo sapiens_hsa04924 | 1.57289390 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.57095801 |
| 31 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.56041620 |
| 32 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.55027619 |
| 33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.53841454 |
| 34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.53624155 |
| 35 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.53358047 |
| 36 | GABAergic synapse_Homo sapiens_hsa04727 | 1.52508070 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.51936621 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.51639346 |
| 39 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.49140454 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.48323000 |
| 41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.47743925 |
| 42 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.47179549 |
| 43 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.46528663 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 1.44357195 |
| 45 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.43762762 |
| 46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.42448547 |
| 47 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.42345575 |
| 48 | Alzheimers disease_Homo sapiens_hsa05010 | 1.38833141 |
| 49 | Morphine addiction_Homo sapiens_hsa05032 | 1.38720870 |
| 50 | Salivary secretion_Homo sapiens_hsa04970 | 1.34265799 |
| 51 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 1.33593241 |
| 52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.33510980 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31488818 |
| 54 | Bile secretion_Homo sapiens_hsa04976 | 1.30939449 |
| 55 | Parkinsons disease_Homo sapiens_hsa05012 | 1.30875268 |
| 56 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.30399518 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.24948368 |
| 58 | Long-term depression_Homo sapiens_hsa04730 | 1.23695586 |
| 59 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.20604632 |
| 60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.19366951 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.18086220 |
| 62 | Taste transduction_Homo sapiens_hsa04742 | 1.15050685 |
| 63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.14146138 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.13544704 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.12736351 |
| 66 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.12065423 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.12038676 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.11193006 |
| 69 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.10600577 |
| 70 | * Circadian rhythm_Homo sapiens_hsa04710 | 1.06538484 |
| 71 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.03336798 |
| 72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.03139178 |
| 73 | Gap junction_Homo sapiens_hsa04540 | 0.99491289 |
| 74 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.98229503 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.96463605 |
| 76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.93690971 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.93360508 |
| 78 | * Insulin resistance_Homo sapiens_hsa04931 | 0.93251131 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.90682353 |
| 80 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.88951283 |
| 81 | Tight junction_Homo sapiens_hsa04530 | 0.88263082 |
| 82 | Lysine degradation_Homo sapiens_hsa00310 | 0.87251145 |
| 83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86508928 |
| 84 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.86401220 |
| 85 | Focal adhesion_Homo sapiens_hsa04510 | 0.85970197 |
| 86 | Melanogenesis_Homo sapiens_hsa04916 | 0.84849506 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.84162948 |
| 88 | Glioma_Homo sapiens_hsa05214 | 0.83014761 |
| 89 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82473867 |
| 90 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.82320203 |
| 91 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.81725996 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81604558 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79800219 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79255008 |
| 95 | Cocaine addiction_Homo sapiens_hsa05030 | 0.78645886 |
| 96 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.78322103 |
| 97 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.77067075 |
| 98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.76915394 |
| 99 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.76397915 |
| 100 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75939068 |
| 101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.75778459 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.75317535 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75117580 |
| 104 | Huntingtons disease_Homo sapiens_hsa05016 | 0.74206956 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73978957 |
| 106 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.72687791 |
| 107 | Axon guidance_Homo sapiens_hsa04360 | 0.72329571 |
| 108 | Peroxisome_Homo sapiens_hsa04146 | 0.72002084 |
| 109 | * Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.70523109 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69307585 |
| 111 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68233787 |
| 112 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67741406 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66377502 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65665959 |
| 115 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64904753 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63268561 |
| 117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63048912 |
| 118 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61576411 |
| 119 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60116112 |
| 120 | Carbon metabolism_Homo sapiens_hsa01200 | 0.59772301 |
| 121 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.59641411 |
| 122 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59580187 |
| 123 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58689950 |
| 124 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58493171 |
| 125 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.57918952 |
| 126 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.57268867 |
| 127 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56990894 |
| 128 | ABC transporters_Homo sapiens_hsa02010 | 0.56466861 |
| 129 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.55868792 |
| 130 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54431043 |
| 131 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54187928 |
| 132 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53823738 |
| 133 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53502387 |
| 134 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.52440036 |
| 135 | Prion diseases_Homo sapiens_hsa05020 | 0.52111006 |
| 136 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51667501 |
| 137 | Platelet activation_Homo sapiens_hsa04611 | 0.51566624 |
| 138 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51411627 |
| 139 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50720407 |
| 140 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.49317029 |
| 141 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49183158 |
| 142 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48826895 |
| 143 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47568988 |
| 144 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45031696 |
| 145 | Amoebiasis_Homo sapiens_hsa05146 | 0.44174250 |
| 146 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.43664454 |
| 147 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.43497025 |
| 148 | Phototransduction_Homo sapiens_hsa04744 | 0.42559197 |
| 149 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.42462156 |
| 150 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42031407 |
| 151 | Adherens junction_Homo sapiens_hsa04520 | 0.41793167 |
| 152 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41037735 |
| 153 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.40773432 |
| 154 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40157789 |
| 155 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39442484 |
| 156 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.39194132 |
| 157 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37362196 |
| 158 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.36671878 |
| 159 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.34270969 |
| 160 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.29192526 |
| 161 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.26835087 |
| 162 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.25608614 |
| 163 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.25267977 |

